Clavulanic Acid Potassium Salt

• CAT Number: R004595
• CAS Number: 61177-45-5
• Molecular Formula: C8H8KNO5
• Molecular Weight: 237.25
• Purity: ≥95%
• Synonyms: MM 1415; Potassium Clavulanate
• Target: Beta-lactamase
• Solubility: Soluble in DMSO
• Appearance: White or almost white powder
• Storage: Store at -20°C
• IUPAC Name: potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
• InChI: InChI=1S/C8H9NO5.K/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/q;+1/p-1/b4-1-;/t6-,7-;/m1./s1
• InChIKey: ABVRVIZBZKUTMK-JSYANWSFSA-M
• SMILES: C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)[O-].[K+]

Clavulanic Acid Potassium Salt（Cat No.:R004595）is a potent beta-lactamase inhibitor commonly used in combination with beta-lactam antibiotics to enhance their effectiveness against resistant bacterial strains. By inhibiting beta-lactamase enzymes, it prevents the breakdown of antibiotics, thereby restoring their antibacterial activity. Often paired with amoxicillin, Clavulanic Acid extends the spectrum of treatment against a broad range of infections. Its stable salt form allows for better absorption and stability in pharmaceutical formulations. Clavulanic Acid is a crucial agent in combating antibiotic resistance and is widely used in both medical and research applications.

Reference

1: Abdel-Aziz MI, Ali MA, Hassan AK, Elfaham TH. Warfarin-drug interactions: An
emphasis on influence of polypharmacy and high doses of amoxicillin/clavulanate.
J Clin Pharmacol. 2016 Jan;56(1):39-46. doi: 10.1002/jcph.583. Epub 2015 Sep 29.
PubMed PMID: 26138877.
2: Ferrer P, Amelio J, Ballarín E, Sabaté M, Vidal X, Rottenkolber M, Schmiedl S,
Laporte JR, Ibáñez L; PROTECT Work Package 2.. Systematic Review and
Meta-Analysis: Macrolides and Amoxicillin/Clavulanate-induced Acute Liver Injury.
Basic Clin Pharmacol Toxicol. 2015 Dec 26. doi: 10.1111/bcpt.12550. [Epub ahead
of print] PubMed PMID: 26707367.
3: Wan KS, Wu WF, Chen TC, Wu CS, Hung CW, Chang YS. Comparison of amoxicillin +
clavulanate with or without intranasal fluticasone for the treatment of
uncomplicated acute rhinosinusitis in children. Minerva Pediatr. 2015
Dec;67(6):489-94. PubMed PMID: 26530491.
4: Sutherland CA, Crandon JL, Nicolau DP. Defining Extended Spectrum
β-Lactamases: Implications of Minimum Inhibitory Concentration-Based Screening
Versus Clavulanate Confirmation Testing. Infect Dis Ther. 2015 Oct 20. [Epub
ahead of print] PubMed PMID: 26481506; PubMed Central PMCID: PMC4675766.
5: Rossi B, Soubirou JF, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort
A. Cefotaxime and Amoxicillin-Clavulanate Synergism against
Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of
Urinary Tract Infection. Antimicrob Agents Chemother. 2015 Nov 2;60(1):424-30.
doi: 10.1128/AAC.02018-15. PubMed PMID: 26525800.
6: Soroka D, Li de la Sierra-Gallay I, Dubée V, Triboulet S, van Tilbeurgh H,
Compain F, Ballell L, Barros D, Mainardi JL, Hugonnet JE, Arthur M. Hydrolysis of
clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical
SDN motif. Antimicrob Agents Chemother. 2015 Sep;59(9):5714-20. doi:
10.1128/AAC.00598-15. Epub 2015 Jul 6. PubMed PMID: 26149997; PubMed Central
PMCID: PMC4538473.
7: Goodwani S, Rao PS, Bell RL, Sari Y. Amoxicillin and amoxicillin/clavulanate
reduce ethanol intake and increase GLT-1 expression as well as AKT
phosphorylation in mesocorticolimbic regions. Brain Res. 2015 Oct 5;1622:397-408.
doi: 10.1016/j.brainres.2015.07.008. Epub 2015 Jul 10. PubMed PMID: 26168897;
PubMed Central PMCID: PMC4562883.
8: Palmero D, González Montaner P, Cufré M, García A, Vescovo M, Poggi S. First
series of patients with XDR and pre-XDR TB treated with regimens that included
meropenen-clavulanate in Argentina. Arch Bronconeumol. 2015 Oct;51(10):e49-52.
doi: 10.1016/j.arbres.2015.03.012. Epub 2015 May 27. English, Spanish. PubMed
PMID: 26026689.
9: Pagliotto AD, Caleffi-Ferracioli KR, Lopes MA, Baldin VP, Leite CQ, Pavan FR,
Scodro RB, Siqueira VL, Cardoso RF. Anti-Mycobacterium tuberculosis activity of
antituberculosis drugs and amoxicillin/clavulanate combination. J Microbiol
Immunol Infect. 2015 Sep 21. pii: S1684-1182(15)00849-X. doi:
10.1016/j.jmii.2015.08.025. [Epub ahead of print] PubMed PMID: 26454420.
10: Kim SH, Saide K, Farrell J, Faulkner L, Tailor A, Ogese M, Daly AK,
Pirmohamed M, Park BK, Naisbitt DJ. Characterization of amoxicillin- and
clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced
liver injury. Hepatology. 2015 Sep;62(3):887-99. doi: 10.1002/hep.27912. Epub
2015 Jul 23. PubMed PMID: 25998949.
11: Álvarez Otero J, González González L, Enríquez Gómez H, de la Fuente Aguado
J. [Cholestatic hepatitis caused by amoxicillin-clavulanate of torpid evolution].
Enferm Infecc Microbiol Clin. 2015 Jul 8. pii: S0213-005X(15)00250-5. doi:
10.1016/j.eimc.2015.06.004. [Epub ahead of print] Spanish. PubMed PMID: 26164264.
12: Martín-Barrasa JL, Méndez Cordovez C, Espinosa de los Monteros y Zayas A,
Juste de Santa Ana MC, Clavo Varas B, Herráez Thomas P, Bordes Benitez A,
Montoya-Alonso JA, García-Bello M, Artiles Campelo F, Tejedor-Junco MT. Rectal
pre-treatment with ozonized oxygen (O3) aggravates clinic status in septic rats
treated with amoxicillin/clavulanate. Enferm Infecc Microbiol Clin. 2015
Aug-Sep;33(7):469-75. doi: 10.1016/j.eimc.2014.09.006. Epub 2014 Nov 4. PubMed
PMID: 25459192.
13: Egesborg P, Carlettini H, Volpato JP, Doucet N. Combinatorial active-site
variants confer sustained clavulanate resistance in BlaC β-lactamase from
Mycobacterium tuberculosis. Protein Sci. 2015 Apr;24(4):534-44. doi:
10.1002/pro.2617. Epub 2014 Dec 30. PubMed PMID: 25492589; PubMed Central PMCID:
PMC4380984.
14: Cielecka-Piontek J, Paczkowska M, Zalewski P, Lewandowska K, Barszcz B.
Solid-state stability and compatibility studies of clavulanate potassium. Pharm
Dev Technol. 2015 Mar;20(2):146-52. doi: 10.3109/10837450.2013.852571. Epub 2013
Nov 13. PubMed PMID: 24219797.
15: Ferrer P, Sabaté M, Ballarín E, Fortuny J, Rottenkolber M, Schmiedl S,
Laporte JR, Ibáñez L. Sales of macrolides, lincosamides, streptogramins, and
amoxicillin/clavulanate in the in- and outpatient setting in 10 European
countries, 2007-2010. Springerplus. 2015 Oct 15;4:612. doi:
10.1186/s40064-015-1398-4. eCollection 2015. PubMed PMID: 26543747; PubMed
Central PMCID: PMC4628133.
16: Lemieux P, Grégoire JP, Thibeault R, Bergeron L. Higher risk of neutropenia
associated with piperacillin-tazobactam compared with ticarcillin-clavulanate in
children. Clin Infect Dis. 2015 Jan 15;60(2):203-7. doi: 10.1093/cid/ciu780. Epub
2014 Oct 9. PubMed PMID: 25301207.
17: Cielecka-Piontek J, Szymanowska-Powałowska D, Paczkowska M, Łysakowski P,
Zalewski P, Garbacki P. Stability, compatibility and microbiological activity
studies of meropenem-clavulanate potassium. J Antibiot (Tokyo). 2015
Jan;68(1):35-9. doi: 10.1038/ja.2014.92. Epub 2014 Jul 30. PubMed PMID: 25074659.
18: Nguyen HM, Labreche MJ, Graber CJ. Making sense of cephalosporin and
amoxicillin/clavulanate susceptibility testing for uropathogens. Clin Infect Dis.
2014 Nov 1;59(9):1349-50. doi: 10.1093/cid/ciu574. Epub 2014 Jul 16. PubMed PMID:
25034428.
19: Iglesias-Martín F, García-Perla-García A, Yañez-Vico R, Aced-Jiménez E,
Arjona-Gerveno E, González-Padilla JD, Gutierrez-Pérez JL, Torres-Lagares D.
Comparative trial between the use of amoxicillin and amoxicillin clavulanate in
the removal of third molars. Med Oral Patol Oral Cir Bucal. 2014 Nov
1;19(6):e612-5. PubMed PMID: 24880449; PubMed Central PMCID: PMC4259379.
20: Jadhav KS, Marathe PA. Evaluation of potassium clavulanate on ethanol
consumption and decision making in the model of ethanol dependence in mice. J
Pharmacol Pharmacother. 2014 Oct;5(4):250-2. doi: 10.4103/0976-500X.142439.
PubMed PMID: 25422566; PubMed Central PMCID: PMC4231555.